A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of RO7303509 in Participants With Systemic Sclerosis
Clinical trial NCT05462522 · COMPLETED
Trial details
- NCT number
- NCT05462522
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-16
- Primary completion
- 2025-07-11
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.